bf/NASDAQ:CPRX_icon.jpeg

COM:CATALYSTPHARMA

Catalyst Pharmaceuticals, Inc.

  • Stock

USD

Last Close

21.12

22/11 21:00

Market Cap

1.83B

Beta: -

Volume Today

863.01K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-12.15M
-
-15.51M
27.60%
-20.23M
30.46%
-18.07M
10.68%
-18.41M
1.88%
-34.00M
84.68%
31.88M
193.74%
74.98M
135.24%
39.48M
47.35%
83.08M
110.42%
71.41M
14.05%
depreciation and amortization
22.48K
-
26.57K
18.20%
34.47K
29.71%
43.41K
25.93%
45.69K
5.26%
37.98K
16.88%
297.73K
683.94%
885.32K
197.36%
192K
78.31%
1.24M
545.31%
33.14M
2,574.98%
deferred income tax
-175.85K
-
-1.65M
-
-32.97M
-
9.32M
128.25%
4.94M
47.01%
-17.82M
460.91%
stock based compensation
175.85K
-
777.97K
342.39%
1.59M
103.79%
1.84M
15.81%
2.41M
31.15%
3.55M
47.45%
3.82M
7.72%
6.26M
63.69%
6.07M
3.00%
7.91M
30.20%
14.25M
80.22%
change in working capital
190.22K
-
768.87K
304.19%
662.82K
13.79%
-884.40K
233.43%
2.03M
329.45%
4.71M
132.13%
-1.10M
123.26%
-4.11M
275.22%
5.02M
222.16%
13.73M
173.38%
-37.32M
371.86%
accounts receivables
-10.54M
-
4.55M
143.18%
-632K
113.89%
-3.82M
504.43%
-43.08M
1,027.62%
inventory
-56.01K
-
-1.90M
3,293.52%
-2.69M
41.72%
-3.22M
19.50%
1.06M
133.08%
-4.74M
544.98%
accounts payables
-514.87K
-
963.42K
287.12%
-20.08K
102.08%
-860.95K
4,186.96%
1.01M
217.59%
391.79K
61.30%
1.78M
354.34%
138.57K
92.22%
-1.49M
1,173.80%
1.21M
181.12%
10.82M
796.44%
other working capital
705.10K
-
-194.55K
127.59%
682.90K
451.01%
-23.45K
103.43%
1.02M
4,435.52%
4.37M
330.22%
9.56M
118.58%
-6.11M
163.85%
10.36M
269.71%
15.28M
47.45%
-330K
102.16%
other non cash items
2.07M
-
993.87K
51.90%
1.59M
59.52%
-886.14K
155.89%
186.90K
121.09%
-290.81K
-
-12.19K
95.81%
287K
2,454.20%
5.16M
1,696.52%
79.94M
1,450.41%
net cash provided by operating activities
-9.88M
-
-12.94M
31.05%
-18.02M
39.20%
-17.96M
0.29%
-13.74M
23.50%
-25.70M
87.04%
34.61M
234.65%
45.03M
30.12%
60.37M
34.06%
116.05M
92.22%
143.60M
23.74%
investments in property plant and equipment
-9.43K
-
-57.32K
507.75%
-23.46K
59.07%
-96.06K
309.38%
-92.02K
-
-19.37K
78.95%
-11.40K
41.15%
-1.02M
8,857.71%
-29K
97.16%
-198.52M
684,465.52%
acquisitions net
23.46K
-
23.46K
0%
-37.24M
-
5M
113.42%
10M
-
purchases of investments
-7.49M
-
-8.68M
15.98%
-1.85K
99.98%
-68.60K
3,616.31%
-3.96K
94.23%
-36.80M
929,723.60%
-34.73M
5.64%
-10M
71.20%
-10M
0%
-10M
0%
-13.46M
34.65%
sales maturities of investments
18.81K
-
3.72M
19,659.88%
21.37M
-
71.97M
236.80%
5M
93.05%
19.24M
-
other investing activites
-23.46K
-
-23.46K
0%
37.24M
-
-5M
113.42%
-10M
-
-81.51M
715.13%
net cash used for investing activites
-7.50M
-
-8.74M
16.60%
-6.50K
99.93%
3.55M
54,763.26%
-3.96K
100.11%
-15.53M
392,169.10%
37.22M
339.76%
-5.01M
113.46%
-11.02M
119.92%
9.21M
183.56%
-293.50M
3,287.12%
debt repayment
common stock issued
14.07M
-
26.73M
89.92%
34.87M
30.49%
34.87M
0%
53.77M
54.19%
1.12M
-
758.13K
32.08%
4.10M
440.67%
4.10M
0%
2.79M
31.89%
common stock repurchased
-56K
-
-12.09M
21,487.50%
-6.91M
42.87%
dividends paid
other financing activites
4.11M
-
1.84M
55.23%
2.29M
24.35%
-34.80M
1,622.46%
3.58M
110.28%
293.12K
91.81%
1.12M
280.74%
-197
100.02%
-153K
77,564.97%
4.50M
3,042.48%
-13.65M
403.18%
net cash used provided by financing activities
18.18M
-
28.56M
57.13%
37.16M
30.10%
68.99K
99.81%
57.35M
83,033.05%
293.12K
99.49%
1.12M
280.82%
701.93K
37.12%
-8.14M
1,260.08%
1.69M
120.80%
-10.86M
740.91%
effect of forex changes on cash
net change in cash
806.02K
-
6.88M
753.68%
19.14M
178.14%
-14.34M
174.94%
43.60M
404.03%
-40.94M
193.89%
72.95M
278.20%
40.73M
44.18%
41.21M
1.19%
126.95M
208.07%
-160.76M
226.63%
cash at beginning of period
1.41M
-
2.22M
57.17%
9.10M
310.51%
28.24M
210.38%
13.89M
50.79%
57.50M
313.85%
16.56M
71.20%
89.51M
440.55%
130.24M
45.50%
171.44M
31.64%
298.39M
74.05%
cash at end of period
2.22M
-
9.10M
310.51%
28.24M
210.38%
13.89M
50.79%
57.50M
313.85%
16.56M
71.20%
89.51M
440.55%
130.24M
45.50%
171.44M
31.64%
298.39M
74.05%
137.64M
53.87%
operating cash flow
-9.88M
-
-12.94M
31.05%
-18.02M
39.20%
-17.96M
0.29%
-13.74M
23.50%
-25.70M
87.04%
34.61M
234.65%
45.03M
30.12%
60.37M
34.06%
116.05M
92.22%
143.60M
23.74%
capital expenditure
-9.43K
-
-57.32K
507.75%
-23.46K
59.07%
-96.06K
309.38%
-92.02K
-
-19.37K
78.95%
-11.40K
41.15%
-1.02M
8,857.71%
-29K
97.16%
-198.52M
684,465.52%
free cash flow
-9.89M
-
-13.00M
31.50%
-18.04M
38.77%
-18.06M
0.12%
-13.74M
23.90%
-25.80M
87.71%
34.59M
234.10%
45.02M
30.16%
59.35M
31.82%
116.02M
95.48%
-54.92M
147.34%

All numbers in USD (except ratios and percentages)